The global anal irrigation systems market is estimated to grow at a CAGR of 3.31% during the forecast period from 2024 to 2030. The increasing demand for anal irrigation systems is primarily driven by the growing prevalence of constipation and its risk factors such as obesity, indigestion, and diabetes. Unhealthy dietary habits, rising cases of colon cancer, and the increasing geriatric population are also contributing factors. This trend is expected to continue during the forecast period from 2024-2030.
In addition, there is evidence of an age-related rise in the prevalence of constipation, with 30 - 40% of people over 65 years of age reporting problems with it on average, globally. Constipation is more common in women than in men overall, and its pathophysiology is influenced by a variety of factors including nutrition, hydration levels, lifestyle choices, and underlying medical disorders.
Moreover, the growing number of obesity and diabetes cases among people act as potential risk factors for the growth for the anal irrigation systems market. For instance, according to the World Obesity Federation (2022), it is predicted that one billion people around the world, including 1 in 5 women and 1 in 7 men, will be living with obesity by 2030.
As per reports by the International Diabetes Foundation (2021), approximately 537 million adults (20-79 years) were living with diabetes worldwide. The source further stated that the total number of people living with diabetes globally is projected to rise to 643 million by 2030 and 783 million by 2045. Lifestyle-related diseases such as diabetes and obesity cases interfere with digestion, raising blood sugar levels, thus acting as a barrier for excretion by restricting bowel movements. Thus, the increasing prevalence of all the above-mentioned factors is expected to increase the cases of constipation, driving the demand for anal irrigation systems in the anal irrigation systems market during the forecast period.
However, the various complications associated with the use of anal irrigation systems may act as a prominent factor that is expected to limit the growth of the Anal Irrigation Systems market during the forecast period.
In the product type segment of the anal irrigation systems market, the balloon catheter devices category is estimated to amass a significant revenue share in the Anal Irrigation Systems market in 2023. This can be attributed to the various advantages associated with balloon catheter devices and the rising product development activities specific to this category, in the upcoming years.
Balloon catheters are indicated for people who have trouble keeping a cone in place or who require a better seal to infuse the irrigation water. The balloon catheters integrate well with a changing lifestyle and are more convenient to carry around.
When treating a variety of anal injuries, such as fecal incontinence and persistent constipation, balloon catheters are utilized as a diagnostic imaging technique to evaluate the anal function of the patient. It is anticipated that the use of balloon catheters in the management of different anal injuries will accelerate market expansion.
According to the CDC (2022), chronic idiopathic constipation (CIC) is a widespread functional illness that affects around 10-17% of the global population. Therefore, it is anticipated that the high prevalence of chronic constipation and fecal incontinence in the world's population will support the expansion of balloon catheter devices owing to their various advantages during the given forecast period from 2024-2030.
According to GI Alliance data (2021), 20 million Americans are affected with chronic digestive illnesses annually. Digestive illnesses are one of the nation's most critical health problems in terms of discomfort and agony, since they hospitalize more Americans than any other condition. Digestive illnesses are one of America’s most critical health problems in terms of discomfort and agony, since they hospitalize more Americans than any other condition. According to the source, fourteen million cases of acute digestive disorders are treated in the country on average each year, accounting for one-third of all malignancies and some of the most prevalent acute infections.
In addition, in July 2021, data published by the Public Health Agency of Canada stated that nearly 260,000 Canadians were diagnosed with inflammatory bowel diseases in 2021. Such prevalence of inflammatory bowel diseases among the population of Canada is expected to contribute to the growing demand for anal irrigation systems.
The presence of key market players such as Becton, Dickinson and Company, Dentsply Sirona, Consure Medical Pvt. Ltd. in the US is also expected to raise significant regional revenue from the North America region.
Thus, the rising incidence of IBD, constipation, unhealthy dietary habits, among the population in North America, presence of key players, among others will eventually drive the overall market for Anal Irrigation Systems in North America during the forecast period.
This product will be delivered within 2 business days.
Anal Irrigation Systems Market Dynamics:
According to data from the research study “Global prevalence of functional constipation according to the Rome criteria (2021)”, functional constipation affects between one in six and one in ten people on average globally, at any point in time. In children, a prevalent form of constipation known as functional constipation is characterized by difficult and infrequent bowel motions that do not appear to have an obvious anatomical or organic reason. As per the same source, childhood functional constipation is highly prevalent, having a prevalence of approximately 29.6% in 2021 worldwide.In addition, there is evidence of an age-related rise in the prevalence of constipation, with 30 - 40% of people over 65 years of age reporting problems with it on average, globally. Constipation is more common in women than in men overall, and its pathophysiology is influenced by a variety of factors including nutrition, hydration levels, lifestyle choices, and underlying medical disorders.
Moreover, the growing number of obesity and diabetes cases among people act as potential risk factors for the growth for the anal irrigation systems market. For instance, according to the World Obesity Federation (2022), it is predicted that one billion people around the world, including 1 in 5 women and 1 in 7 men, will be living with obesity by 2030.
As per reports by the International Diabetes Foundation (2021), approximately 537 million adults (20-79 years) were living with diabetes worldwide. The source further stated that the total number of people living with diabetes globally is projected to rise to 643 million by 2030 and 783 million by 2045. Lifestyle-related diseases such as diabetes and obesity cases interfere with digestion, raising blood sugar levels, thus acting as a barrier for excretion by restricting bowel movements. Thus, the increasing prevalence of all the above-mentioned factors is expected to increase the cases of constipation, driving the demand for anal irrigation systems in the anal irrigation systems market during the forecast period.
However, the various complications associated with the use of anal irrigation systems may act as a prominent factor that is expected to limit the growth of the Anal Irrigation Systems market during the forecast period.
Anal Irrigation Systems Market Segment Analysis:
Anal Irrigation Systems market by Product Type (Balloon Catheter Devices, Cone Devices, Bed Systems, and Others), End-User (Hospitals, Ambulatory Surgical Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)In the product type segment of the anal irrigation systems market, the balloon catheter devices category is estimated to amass a significant revenue share in the Anal Irrigation Systems market in 2023. This can be attributed to the various advantages associated with balloon catheter devices and the rising product development activities specific to this category, in the upcoming years.
Balloon catheters are indicated for people who have trouble keeping a cone in place or who require a better seal to infuse the irrigation water. The balloon catheters integrate well with a changing lifestyle and are more convenient to carry around.
When treating a variety of anal injuries, such as fecal incontinence and persistent constipation, balloon catheters are utilized as a diagnostic imaging technique to evaluate the anal function of the patient. It is anticipated that the use of balloon catheters in the management of different anal injuries will accelerate market expansion.
According to the CDC (2022), chronic idiopathic constipation (CIC) is a widespread functional illness that affects around 10-17% of the global population. Therefore, it is anticipated that the high prevalence of chronic constipation and fecal incontinence in the world's population will support the expansion of balloon catheter devices owing to their various advantages during the given forecast period from 2024-2030.
North America Is Expected To Dominate The Overall Anal Irrigation Systems Market:
North America is expected to account for the highest proportion of the Anal Irrigation Systems Market in 2023, out of all regions. This is due to the presence of a large patient pool suffering from constipation, inflammatory bowel disease, and its risk factors in North America. Additionally, the growing geriatric population vulnerable to constipation, and the presence of key market players, developed and sophisticated healthcare infrastructure in the region are some of the key factors driving the growth of the Anal Irrigation Systems market in North America.According to GI Alliance data (2021), 20 million Americans are affected with chronic digestive illnesses annually. Digestive illnesses are one of the nation's most critical health problems in terms of discomfort and agony, since they hospitalize more Americans than any other condition. Digestive illnesses are one of America’s most critical health problems in terms of discomfort and agony, since they hospitalize more Americans than any other condition. According to the source, fourteen million cases of acute digestive disorders are treated in the country on average each year, accounting for one-third of all malignancies and some of the most prevalent acute infections.
In addition, in July 2021, data published by the Public Health Agency of Canada stated that nearly 260,000 Canadians were diagnosed with inflammatory bowel diseases in 2021. Such prevalence of inflammatory bowel diseases among the population of Canada is expected to contribute to the growing demand for anal irrigation systems.
The presence of key market players such as Becton, Dickinson and Company, Dentsply Sirona, Consure Medical Pvt. Ltd. in the US is also expected to raise significant regional revenue from the North America region.
Thus, the rising incidence of IBD, constipation, unhealthy dietary habits, among the population in North America, presence of key players, among others will eventually drive the overall market for Anal Irrigation Systems in North America during the forecast period.
Anal Irrigation Systems Market Key Players:
Some of the key market players operating in the anal irrigation systems market include BD, B. Braun Melsungen AG, Coloplast A/S, Consure Medical Pvt. Ltd., UroMed Kurt Drews KG, Dentsply Sirona, Ostomed, ABC Medical, Inc., ProSys International Ltd., MBH-International A/S, Aquaflush Medical Limited, ConvaTec Group PLC, HTKD Medical, Qufora, Runfold Plastics Ltd., and others.Recent Developmental Activities In The Anal Irrigation Systems Market:
- In April 2023, Wellspect HealthCare released Navina Mini, a minimally invasive low-volume anal irrigation product, simplifying evaluation difficulties and symptoms of incomplete soiling or emptying.
- In June 2022, a three-year group purchase agreement for urological supplies was forged between Hollister Incorporated and Vizient, Inc. Through negotiated pricing, the new arrangement will give Vizient members greater access to the whole line of urological goods from Hollister Incorporated.
- In December 2021, The US FDA approved USMIMA SL's initial product, the MOWOOT II intestinal transit management system. The Mowoot device proved to be safe, to have a high clinical responder status, and to enhance the quality of life for patients.
Key Takeaways From The Anal Irrigation Systems Market Report Study
- Market size analysis for current Anal Irrigation Systems Market size (2023), and market forecast for 6 years (2024-2030)
- Top key product/technology developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years
- Key companies dominating the global Anal Irrigation Systems market.
- Various opportunities available for the other competitors in the Anal Irrigation Systems Market space.
- What are the top-performing segments in 2023? How these segments will perform in 2030?
- Which are the top-performing regions and countries in the current Anal Irrigation Systems market scenario?
- Which are the regions and countries where companies should have concentrated on opportunities for Anal Irrigation Systems market growth in the coming future?
Target Audience Who Can Be Benefited From This Anal Irrigation Systems Market Report Study
- Anal Irrigation Systems product providers
- Research organizations and consulting companies
- Anal Irrigation Systems-related organizations, associations, forums, and other alliances
- Government and corporate offices
- Start-up companies, venture capitalists, and private equity firms
- Distributors and Traders dealing in Anal Irrigation Systems
- Various end-users who want to know more about the Anal Irrigation Systems Market and the latest technological developments in the Anal Irrigation Systems Market.
Frequently Asked Questions For The Anal Irrigation Systems Market:
1. What are Anal Irrigation Systems?
Anal irrigation systems, also known as transanal irrigation or bowel irrigation, are medical devices used to help empty the lower bowel and treat certain bowel conditions.2. What is the market for Anal Irrigation Systems?
The global anal irrigation systems market is estimated to grow at a CAGR of 3.31% during the forecast period from 2024 to 2030.3. What are the drivers for the Global Anal Irrigation Systems market?
The Anal Irrigation Systems Market is slated to witness prosperity owing to the growing prevalence of constipation and its risk factors such as obesity, indigestion and diabetes globally, unhealthy dietary habits, rising cases of colon cancer, and the increasing geriatric population, during the forecast period from 2024-2030.4. Who are the key players operating in the global Anal Irrigation Systems market?
Some of the key market players operating in the anal irrigation systems market include BD, B. Braun Melsungen AG, Coloplast A/S, Consure Medical Pvt. Ltd., UroMed Kurt Drews KG, Dentsply Sirona, Ostomed, ABC Medical, Inc., ProSys International Ltd., MBH-International A/S, Aquaflush Medical Limited, ConvaTec Group PLC, HTKD Medical, Qufora, Runfold Plastics Ltd., and others.5. Which region has the highest share in the Global Anal Irrigation Systems market?
North America is expected to dominate the overall Anal Irrigation Systems market during the forecast period from 2024 to 2030. This is due to the presence of a large patient pool suffering from constipation, inflammatory bowel disease, and its risk factors in North America. Additionally, the growing geriatric population vulnerable to have constipation, and the presence of key market players, developed and sophisticated healthcare infrastructure in the region are some of the key factors driving the growth of the Anal Irrigation Systems market in North America.This product will be delivered within 2 business days.
Table of Contents
1. Anal Irrigation Systems Market Report Introduction
2. Anal Irrigation Systems Market Executive Summary
4. Regulatory Analysis
5. Anal Irrigation Systems Market Key Factors Analysis
6. Anal Irrigation Systems Market Porter’s Five Forces Analysis
7. Anal Irrigation Systems Market Assessment
8. Anal Irrigation Systems Market Company and Product Profiles
List of Tables
List of Figures
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- BD
- B. Braun Melsungen AG
- Coloplast A/S
- Consure Medical Pvt. Ltd
- UroMed Kurt Drews KG
- Dentsply Sirona
- Ostomed
- ABC Medical, Inc.
- ProSys International Ltd.
- MBH-International A/S
- Aquaflush Medical Limited
- ConvaTec Group PLC
- HTKD Medical
- Qufora
- Runfold Plastics Ltd.